Icahn accuses Forest of hiding poison pill pacts
Reuters : Sat Aug 11 2012, 03:12 hrs
Related
Top Stories
- Police on money trail, Sreesanth in fresh trouble
- Chinese Premier Li Keqiang arrives today, PM to seek early revival of border talks
- Disabled girls say raped in Rajasthan school, 4 arrested
- Kataria ideal man, Sohrabuddin had to die: RSS-affiliated outfit
- Gunmen kill senior woman member of Pakistani party led by Imran Khan
Activist investor Carl Icahn, engaged in a bitter proxy battle with Forest Laboratories, accused the drugmaker of hiding information from shareholders that might show it has provisions built into its licensing agreements that would deter a potential suitor. Icahn said on Friday he had asked a Delaware court to allow him to release non-public information to shareholders.
Please read our terms of use before posting comments
TERMS OF USE: The views, opinions and comments posted are your, and are not endorsed by this website. You shall be solely responsible for the comment posted here. The website reserves the right to delete, reject, or otherwise remove any views, opinions and comments posted or part thereof. You shall ensure that the comment is not inflammatory, abusive, derogatory, defamatory &/or obscene, or contain pornographic matter and/or does not constitute hate mail, or violate privacy of any person (s) or breach confidentiality or otherwise is illegal, immoral or contrary to public policy. Nor should it contain anything infringing copyright &/or intellectual property rights of any person(s).
Editors’ Pick
- Quake-hit and shaken, Bhaderwah spends nights in the open
- UP blast accused dies on way to jail, govt wanted to drop case against him
- Former civil aviation secy changes mind, seeks airport security exemption as EC
- BCCI suspects Gujarat players in other teams were also approached
- Police on money trail, Sreesanth in fresh trouble
- Chhattisgarh 'encounter' leaves 8 villagers dead, no Maoist link yet
- Chinese Premier Li Keqiang arrives today, PM to seek early revival of border talks


Audi's $1.3-bn Mexico SUV plant aimed at unseating BMW
Microsoft goes mainstream to win smartphone share
Super-high cancer drug prices run into censure by doctors
Fat tax: Obese fliers should pay extra, says economist




















